FRESH-PEF73987-en
NATIONAL REAL-LIFE STUDY OF LYMPHOMAS
REALYSA
| Name | Country code |
|---|---|
| France | fr |
['Clinical data','Paraclinical data (non-biological)','Paraclinical data (non-biological) : Imaging','Biological data','Socio-demographic data','Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Hematology | health theme |
| Neoplasms of haematopoietic or lymphoid tissues | cim-11 |
| Socio-demographic and economic determinants | health determinant |
| Behavioral determinants | health determinant |
| Behavioral determinants: Eating habits | health determinant |
| Environmental determinants | health determinant |
| Healthcare system determinants: Use of care | health determinant |
| Healthcare system determinants: Access to care | health determinant |
| Socio-demographic and economic determinants: Employment | health determinant |
| Healthcare system determinants | health determinant |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"","clusion_E":""}
| Name |
|---|
| Hervé;GHESQUIERES |
| Fanny;CHERBLANC |
| Name | Role |
|---|---|
| HOSPICES CIVILS DE LYON (HCL) | sponsor |
| LYSARC - THE LYMPHOMA ACADEMIC RESEARCH ORGANISATION | sponsor |
| Name |
|---|
| Interlymph |
| Agency name |
|---|
| CNIL |
| CPP |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Observational Study
| Start | End |
|---|---|
| 2018-01-01 | 2028-01-01 |
| Standard |
|---|
| ['WHO 2016 diagnostic classification, MEDDRA extract for adverse events'] |
['Data validation within eCRF (queries), consistency test in SAS, quality control by sampling with comparison to the source file']
All projects must be validated by the REALYSA Scientific Committee and approved by the LYSA Board, on the basis of a synopsis (available on request). The REALYSA Scientific Committee meets quarterly. A contract will be drawn up for each project.
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
| Name | |
|---|---|
| Fanny;CHERBLANC | fanny.cherblanc@lysarc.org |